Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count greater than 500 cells/μl

被引：20

作者：

Mussini, C ^{[1
]}

Bugarini, R

Perno, CF

Antinori, A

Borghi, V

Bertoli, A

D'Arrigo, R

Bedini, A

Mongiardo, N

Cossarizza, A

Esposito, R

机构：

[1] Univ Modena, Clin Infect & Trop Dis, I-41100 Modena, Italy

[2] Azienda Policlin, I-41100 Modena, Italy

[3] Ist Super Sanita, I-00161 Rome, Italy

[4] IRCCS, Natl Inst Infect Dis L Spallanzani, Rome, Italy

[5] Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy

来源：

AIDS | 2002年 / 16卷 / 11期

关键词：

D O I：

10.1097/00002030-200207260-00013

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

After a median of 37 months on antiretroviral therapy, 16 patients were asked to discontinue treatment instead of changing it. After a median observation time of 10.5 months, most patients experienced a rapid and progressive decrease in their CD4 cell count, even without a high viral load rebound. This decline was unrelated to the CD4 cell count and HIV-RNA values at interruption, but was more profound in patients in whom the M184V mutation had disappeared after lamivudine discontinuation.

引用

页码：1551 / 1554

页数：4

共 50 条

[21] A comparison of the CD4 response to antiretroviral regimens in patients commencing therapy with low CD4 counts
Waters, L
Stebbing, J
Jones, R
Michailidis, C
Sawleshwarkar, S
Mandalia, S
Bower, M
Nelson, M
Gazzard, B
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (02) : 503 - 507
[22] Effect of prolonged discontinuation of successful antiretroviral therapy on CD4 T cells: a controlled, prospective trial
Maggiolo, F
Ripamonti, D
Gregis, G
Quinzan, G
Callegaro, A
Suter, F
AIDS, 2004, 18 (03) : 439 - 446
[23] Incomplete Recovery of CD4 Cell Count, CD4 Percentage, and CD4/CD8 Ratio in Patients With Human Immunodeficiency Virus Infection and Suppressed Viremia During Long-term Antiretroviral Therapy
Mutoh, Yoshikazu
Nishijima, Takeshi
Inaba, Yosuke
Tanaka, Noriko
Kikuchi, Yoshimi
Gatanaga, Hiroyuki
Oka, Shinichi
CLINICAL INFECTIOUS DISEASES, 2018, 67 (06) : 927 - 933
[24] Pneumocystis pneumonia in a person with a low CD4 count after stopping antiretroviral therapy
Ball, Susan C.
AIDS READER, 2007, 17 (12): : 583 - +
[25] Quantification of the relationship between expenditure on antiretroviral therapy and increase in CD4 cell count
Irish Journal of Medical Science, 2001, 170 (Suppl 2)
[26] CD4 T Cell Count Reconstitution in HIV Controllers after Highly Active Antiretroviral Therapy
Okulicz, Jason F.
Grandits, Greg A.
Weintrob, Amy C.
Landrum, Michael L.
Ganesan, Anuradha
Crum-Cianflone, Nancy F.
Agan, Brian K.
Marconi, Vincent C.
CLINICAL INFECTIOUS DISEASES, 2010, 50 (08) : 1187 - 1191
[27] Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?
Wood, E
Hogg, RS
Yip, B
Harrigan, PR
O'Shaughnesy, MV
Montaner, JSG
AIDS, 2003, 17 (05) : 711 - 720
[28] Is the CD4 cell percentage a better marker of immunosuppression than the absolute CD4 cell count in HIV-infected patients with cirrhosis?
Bongiovanni, Marco
Gori, Andrea
Lepri, Alessandro Cozzi
Antinori, Andrea
de Luca, Andrea
Pagano, Gabriella
Chiodera, Alessandro
Puoti, Massimo
Monforte, Antonella d'Arminio
CLINICAL INFECTIOUS DISEASES, 2007, 45 (05) : 650 - 653
[29] Non-uptake of highly active antiretroviral therapy among patients with a CD4 count < 350 cells/μL in the UK
Kober, C.
Johnson, M.
Fisher, M.
Hill, T.
Anderson, J.
Bansi, L.
Gompels, M.
Palfreeman, A.
Dunn, D.
Gazzard, B.
Gilson, R.
Post, F.
Phillips, A. N.
Walsh, J.
Orkin, C.
Delpech, V.
Ainsworth, J.
Leen, C.
Sabin, C. A.
HIV MEDICINE, 2012, 13 (01) : 73 - 78
[30] Viral load (VL) and CD4 cells (CD4) in patients with disseminated tuberculosis (DT) and pulmonary tuberculosis (PT) after highly active antiretroviral therapy (HAART)
Pedreira, J
Juega, J
Castro, MA
Pita, S
Calvo, SL
AIDS, 2000, 14 : S127 - S127

← 1 2 3 4 5 →